- Home
- SDGR vs BLFS Comparison
SDGR vs BLFS Comparison
Compare SDGR & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDGR
- BLFS
- Stock Information
- Founded
- SDGR 1990
- BLFS 1987
- Country
- SDGR United States
- BLFS United States
- Employees
- SDGR 787
- BLFS N/A
- Industry
- SDGR Biotechnology: Pharmaceutical Preparations
- BLFS Medical/Dental Instruments
- Sector
- SDGR Health Care
- BLFS Health Care
- Exchange
- SDGR Nasdaq
- BLFS Nasdaq
- Market Cap
- SDGR 1.5B
- BLFS 1.3B
- IPO Year
- SDGR 2020
- BLFS 1989
- Fundamental
- Price
- SDGR $19.77
- BLFS $27.57
- Analyst Decision
- SDGR Buy
- BLFS Strong Buy
- Analyst Count
- SDGR 8
- BLFS 7
- Target Price
- SDGR $26.75
- BLFS $30.86
- AVG Volume (30 Days)
- SDGR 1.2M
- BLFS 349.3K
- Earning Date
- SDGR 11-05-2025
- BLFS 11-06-2025
- Dividend Yield
- SDGR N/A
- BLFS N/A
- EPS Growth
- SDGR N/A
- BLFS N/A
- EPS
- SDGR N/A
- BLFS N/A
- Revenue
- SDGR $237,917,000.00
- BLFS $93,468,000.00
- Revenue This Year
- SDGR $22.73
- BLFS $25.65
- Revenue Next Year
- SDGR $19.85
- BLFS $14.81
- P/E Ratio
- SDGR N/A
- BLFS N/A
- Revenue Growth
- SDGR 18.59
- BLFS 68.16
- 52 Week Low
- SDGR $16.60
- BLFS $19.10
- 52 Week High
- SDGR $28.47
- BLFS $29.62
- Technical
- Relative Strength Index (RSI)
- SDGR 45.00
- BLFS 52.62
- Support Level
- SDGR $20.10
- BLFS $26.43
- Resistance Level
- SDGR $21.23
- BLFS $28.21
- Average True Range (ATR)
- SDGR 1.07
- BLFS 1.04
- MACD
- SDGR -0.20
- BLFS -0.15
- Stochastic Oscillator
- SDGR 17.93
- BLFS 36.31
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.